Lexicon Pharmaceuticals
LXRX
LXRX
104 hedge funds and large institutions have $657M invested in Lexicon Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 32 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
16% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 32
Holders
104
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.64M | |
| 2 | +$719K | |
| 3 | +$172K | |
| 4 |
Bank of New York Mellon
New York
|
+$155K |
| 5 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
+$121K |
Top Sellers
| 1 | -$3.58M | |
| 2 | -$725K | |
| 3 | -$342K | |
| 4 |
TA
Teton Advisors
Rye,
New York
|
-$278K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$241K |